New Enterprise Associates 14, L.P.

10% owner at INTERLEUKIN GENETICS INC · on record since May 23, 2013
10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
10% owner at Tracon Pharmaceuticals, Inc. · on record since Jan 29, 2015
10% owner at CHAMPIONS SPORTS INC · on record since Mar 24, 2015
10% owner at Mirna Therapeutics, Inc. · on record since Sep 30, 2015
10% owner at ADVANCE TECHNOLOGIES INC · on record since Oct 20, 2015
10% owner at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
10% owner at MULESOFT, INC · on record since Mar 22, 2017
10% owner at APPIAN CORP · on record since May 31, 2017
10% owner at Mersana Therapeutics, Inc. · on record since Jun 27, 2017
10% owner at Strongbridge Biopharma plc · on record since Jan 9, 2018
Director at Mirna Therapeutics, Inc. · on record since Aug 14, 2026
10% owner at Surface Oncology, Inc. · on record since Apr 23, 2018
10% owner at Oyster Point Pharma, Inc. · on record since Oct 30, 2019
10% owner at Galera Therapeutics, Inc. · on record since Nov 12, 2019
10% owner at Casper Sleep Inc. · on record since Feb 12, 2020
10% owner at L&F Acquisition Corp. · on record since Aug 5, 2022
10% owner at Enliven Therapeutics, Inc. · on record since Mar 16, 2020

Insider trading activity of New Enterprise Associates 14, L.P.

Transactions on record: 41; since Aug 6, 2014

Open-market buys: 5; $18M

Open-market sells: 4; $55.2M

Companies traded: 9; last filing Aug 14, 2026

Figures computed from official regulatory filings — .

Companies where New Enterprise Associates 14, L.P. has traded

9 tx · $6M · Aug 14, 2026
3 tx · $201.7K · Jan 25, 2022
2 tx · Sep 16, 2020
10 tx · May 9, 2018
3 tx · $2M · Apr 23, 2018
6 tx · $55M · Feb 15, 2018
2 tx · $2M · Aug 2, 2016
3 tx · $5M · Feb 5, 2015
3 tx · $3M · Aug 6, 2014

Track record of New Enterprise Associates 14, L.P.

Statistical track record

Free

Open-market buys: 7

Last buy: Jul 27, 2026

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of New Enterprise Associates 14, L.P.

Co-insiders of New Enterprise Associates 14, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Mirna Therapeutics, Inc.	Aug 14, 2026	OtherD (derivative)	-2,640,845	—	—	SEC
Mirna Therapeutics, Inc.	Aug 14, 2026	BuyD (derivative)	2,640,845	—	—	SEC
Enliven Therapeutics, Inc.	Jan 25, 2022	Sell	-19,984	1.55 USD	$31K	SEC
Enliven Therapeutics, Inc.	Jan 25, 2022	Sell	-102,952	1.47 USD	$151.3K	SEC
Enliven Therapeutics, Inc.	Jan 25, 2022	Sell	-11,622	1.67 USD	$19.4K	SEC
Mersana Therapeutics, Inc.	Sep 16, 2020	Other	-2,000,000	0.00 USD	—	SEC
Mersana Therapeutics, Inc.	Apr 13, 2020	Other	-4,000,000	0.00 USD	—	SEC
MULESOFT, INC	May 9, 2018	Other	-12,679,970	—	—	SEC
MULESOFT, INC	May 9, 2018	OtherD (derivative)	-12,679,970	—	—	SEC
MULESOFT, INC	May 9, 2018	Other	12,679,970	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	Other	3,179,544	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	OtherD (derivative)	-6,995,000	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	Buy	133,333	15.00 USD	$2M	SEC
APPIAN CORP	Feb 15, 2018	Other	-2,724,202	0.00 USD	—	SEC
APPIAN CORP	Feb 15, 2018	Other	2,724,202	—	—	SEC
APPIAN CORP	Feb 15, 2018	OtherD (derivative)	-2,724,202	0.00 USD	—	SEC
APPIAN CORP	Nov 21, 2017	Other	2,820,516	—	—	SEC
APPIAN CORP	Nov 21, 2017	OtherD (derivative)	-2,820,516	0.00 USD	—	SEC
APPIAN CORP	Nov 21, 2017	Sell	-2,820,516	19.49 USD	$55M	SEC
MULESOFT, INC	Mar 22, 2017	Other	-12,679,970	—	—	SEC
MULESOFT, INC	Mar 22, 2017	OtherD (derivative)	-1,689,436	0.00 USD	—	SEC
MULESOFT, INC	Mar 22, 2017	OtherD (derivative)	-2,064,048	0.00 USD	—	SEC
MULESOFT, INC	Mar 22, 2017	OtherD (derivative)	12,679,970	0.00 USD	—	SEC
MULESOFT, INC	Mar 22, 2017	OtherD (derivative)	-8,000,038	0.00 USD	—	SEC
MULESOFT, INC	Mar 22, 2017	Other	12,359,190	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Mirna Therapeutics, Inc.	Aug 14, 2026	OtherD (derivative)	-2,640,845	—	—	SEC
Mirna Therapeutics, Inc.	Aug 14, 2026	BuyD (derivative)	2,640,845	—	—	SEC
Enliven Therapeutics, Inc.	Jan 25, 2022	Sell	-19,984	1.55 USD	$31K	SEC
Enliven Therapeutics, Inc.	Jan 25, 2022	Sell	-102,952	1.47 USD	$151.3K	SEC
Enliven Therapeutics, Inc.	Jan 25, 2022	Sell	-11,622	1.67 USD	$19.4K	SEC
Mersana Therapeutics, Inc.	Sep 16, 2020	Other	-2,000,000	0.00 USD	—	SEC
Mersana Therapeutics, Inc.	Apr 13, 2020	Other	-4,000,000	0.00 USD	—	SEC
MULESOFT, INC	May 9, 2018	Other	-12,679,970	—	—	SEC
MULESOFT, INC	May 9, 2018	OtherD (derivative)	-12,679,970	—	—	SEC
MULESOFT, INC	May 9, 2018	Other	12,679,970	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	Other	3,179,544	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	OtherD (derivative)	-6,995,000	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	Buy	133,333	15.00 USD	$2M	SEC
APPIAN CORP	Feb 15, 2018	Other	-2,724,202	0.00 USD	—	SEC
APPIAN CORP	Feb 15, 2018	Other	2,724,202	—	—	SEC
APPIAN CORP	Feb 15, 2018	OtherD (derivative)	-2,724,202	0.00 USD	—	SEC
APPIAN CORP	Nov 21, 2017	Other	2,820,516	—	—	SEC
APPIAN CORP	Nov 21, 2017	OtherD (derivative)	-2,820,516	0.00 USD	—	SEC
APPIAN CORP	Nov 21, 2017	Sell	-2,820,516	19.49 USD	$55M	SEC
MULESOFT, INC	Mar 22, 2017	Other	-12,679,970	—	—	SEC
MULESOFT, INC	Mar 22, 2017	OtherD (derivative)	-1,689,436	0.00 USD	—	SEC
MULESOFT, INC	Mar 22, 2017	OtherD (derivative)	-2,064,048	0.00 USD	—	SEC
MULESOFT, INC	Mar 22, 2017	OtherD (derivative)	12,679,970	0.00 USD	—	SEC
MULESOFT, INC	Mar 22, 2017	OtherD (derivative)	-8,000,038	0.00 USD	—	SEC
MULESOFT, INC	Mar 22, 2017	Other	12,359,190	—	—	SEC